The National Commission for Homoeopathy (NCH) has reiterated its stance on when homoeopathic practitioners may operate outside their designated system of medicine. This announcement comes just before the Bombay High Court is set to hear a protracted legal dispute regarding Maharashtra’s Certificate Course in Modern Pharmacology (CCMP). The clarification follows significant protests from practitioners of modern medicine regarding the state’s initiative to register CCMP-qualified homoeopaths with the Maharashtra Medical Council (MMC).

The court’s proceedings, scheduled for later this week, are expected to be crucial as this matter has been unresolved since 2014. Dr Ravi Wankhedkar, the former national president of the Indian Medical Association (IMA), remarked on the possibility of the case nearing a conclusive hearing. He mentioned that the MMC has issued only a single registration so far, with no new registrations occurring since the onset of the controversy.

Details of the NCH Clarification

The clarification issued by the NCH last week appears to address previous ambiguities in its 2022 professional conduct regulations, which contain both restrictions and exceptions. According to these regulations, a homoeopathic practitioner is generally prohibited from practising any alternative system of medicine. However, a notable exception allows practitioners to engage in government health initiatives, provided they receive training or courses sanctioned by an appropriate authority.

Furthermore, the NCH highlighted its BHMS regulations, which endorse the involvement of homoeopathic graduates in government health facilities and national health programmes. This clarification aims to ensure that the specific provisions are duly understood within the broader regulatory framework.

It is essential to note that this clarification does not grant blanket permission for homoeopaths to practice modern medicine. The legal question of whether the CCMP framework in Maharashtra falls under the aforementioned exception and whether the CCMP qualifications justify registration with the modern medicine council remains an issue for the courts to decide.

Importance of the CCMP Programme

The ongoing controversy is rooted in a wider debate surrounding “bridge courses” in India. The primary objective of such courses is to offer additional training to practitioners from various medical backgrounds to facilitate limited primary healthcare, especially in underserved regions. However, these initiatives have consistently faced opposition from modern medical professionals, who assert that the ability to prescribe medication is intrinsically linked to diagnostic training and the capacity to handle complications.

Maharashtra’s CCMP represents a state-specific interpretation of this initiative. Practitioners with a BHMS degree may pursue additional training in modern pharmacology. The situation escalated earlier this year when the state began allowing these practitioners to register with the MMC. An estimated 10,000 BHMS graduates have benefited from completing the CCMP over the years, and this registration issue has become the focal point of the ongoing dispute.

Dr Wankhedkar indicated that the NCH statement is designed to aid the court in comprehending the regulatory implications of the CCMP, suggesting that the commission aims to find a balance among the divergent interests involved. He clarified that limited authority to prescribe specific medications cannot be equated with being included on the statutory register governing modern medical practitioners.

This distinction has been a central theme in the grievance of modern practitioners, with several Indian states permitting practitioners from alternative systems to prescribe defined modern medications under specific conditions. Critics, however, maintain that Maharashtra has overstepped by associating CCMP qualifications with MMC registration. Consequently, the issue transcends the mere ability of homoeopaths to prescribe particular modern drugs and touches upon aspects of professional recognition, registration, and regulation within the context of modern medicine laws. The legal challenge initiated by the IMA and members of the MMC against Maharashtra’s decision has been ongoing since 2014, with the Supreme Court subsequently urging the High Court to expedite the resolution of this matter.

Long or Short, get news the way you like. No ads. No redirections. Download Newspin and Stay Alert, The CSR Journal Mobile app, for fast, crisp, clean updates!

App Store –  https://apps.apple.com/in/app/newspin/id6746449540 

Google Play Store – https://play.google.com/store/apps/details?id=com.inventifweb.newspin&pcampaignid=web_share